Experience

Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience.
Practice
Industry
Region
Featured Matters

Kieback&Peter, an intelligent building automation company, in its strategic partnership with Trane Technologies, a global climate innovator.

Debevoise & Plimpton LLP has advised Kieback&Peter, a Berlin based intelligent building automation company, in its strategic partnership with Trane Technologies, a global climate innovator. Read More>

Atkore in its cooperation agreement with Irenic, relating to the expansion of Atkore’s Board of Directors and its review of strategic alternatives.

Debevoise & Plimpton LLP is advising Atkore Inc. (NYSE: ATKR) in connection with its cooperation agreement with Irenic Capital Management LP, relating to the expansion of Atkore’s Board of Directors and its review of strategic alternatives. For more information, please see the company’s press release. Read More>

Fiduciary Trust Company, a private wealth manager and trust company, in its sale to GTCR.

Debevoise & Plimpton LLP is advising Fiduciary Trust Company, a private wealth manager and trust company, in its sale to GTCR. For more information, please see the GTCR press release. Read More>

MetLife in its role, alongside leading insurer Zurich, in a £6 billion longevity swap transaction with the BBC Pension Scheme.

Debevoise & Plimpton LLP has advised global reinsurer Metropolitan Life Insurance Company (“MetLife”) in its role, alongside leading insurer Zurich Assurance Ltd (“Zurich”), in a longevity swap transaction with the BBC Pension Scheme. Read More>

Resolution Life in its offering of $750 million of 6.875% ancillary Tier 1 notes.

Debevoise & Plimpton LLP has advised Resolution Life in its offering of $750 million of 6.875% ancillary Tier 1 notes (the “Notes”). Read More>

Corebridge Financial in its public offering of $500 million of 6.875% fixed rate reset non-cumulative preferred stock.

Debevoise & Plimpton LLP has advised Corebridge Financial, Inc. (NYSE: CRBG) in its public offering of 500,000 shares of 6.875% fixed rate reset non-cumulative preferred stock, Series A, with a liquidation preference of $1,000 per share for gross proceeds of approximately $495 million. The transaction marks the first preferred stock issuance by Corebridge Financial. Read More>

Carlyle in its acquisition of Tarrytown Expocare Pharmacy, a long-term care pharmacy.

Debevoise & Plimpton LLP has advised Carlyle (NASDAQ: CG) in its acquisition of Tarrytown Expocare Pharmacy, a long-term care pharmacy. For more information, please see the company’s press release. Read More>

CD&R in the financing aspects of its $10.3 billion acquisition of Sealed Air Corporation, a global provider of food and protective packaging solutions.

Debevoise & Plimpton LLP is advising CD&R in the financing and antitrust aspects of its $10.3 billion acquisition of Sealed Air Corporation (NYSE: SEE), a global provider of food and protective packaging solutions. For more information, please see the Sealed Air press release. Read More>

Corebridge Financial and AIG in a secondary public offering of approximately $1 billion of Corebridge common stock, including a repurchase of approximately $500 million of Corebridge common stock.

Debevoise & Plimpton LLP has advised Corebridge Financial, Inc. (NYSE: CRBG) and American International Group, Inc. (NYSE: AIG) in a secondary public offering of approximately $1 billion of Corebridge common stock, including a share repurchase of approximately $500 Million of Corebridge common stock. For more information, please see the company’s press release. Read More>

TPG and OneOncology, a national platform for independent oncology, urology and radiation oncology, in OneOncology’s partnership with Cancer Specialists of North Florida, a provider-owned oncology practice.

Debevoise & Plimpton LLP has advised TPG and OneOncology, a national platform for independent oncology, urology and radiation oncology, in OneOncology’s partnership with Cancer Specialists of North Florida, a provider-owned oncology practice. For more information, please see the company’s press release. Read More>